Chapter 1 Industry Overview

1.1 Definition

1.2 Assumptions

1.3 Research Scope

1.4 Market Analysis by Regions

1.4.1 North America Market States and Outlook (2022-2027)

1.4.2 East Asia Market States and Outlook (2022-2027)

1.4.3 Europe Market States and Outlook (2022-2027)

1.4.4 South Asia Market States and Outlook (2022-2027)

1.4.5 Southeast Asia Market States and Outlook (2022-2027)

1.4.6 Middle East Market States and Outlook (2022-2027)

1.4.7 Africa Market States and Outlook (2022-2027)

1.4.8 Oceania Market States and Outlook (2022-2027)

1.4.9 South America Market States and Outlook (2022-2027)

1.5 Global Anti-tumor Drug Market Size Analysis from 2022 to 2027

1.5.1 Global Anti-tumor Drug Market Size Analysis from 2022 to 2027 by Consumption Volume

1.5.2 Global Anti-tumor Drug Market Size Analysis from 2022 to 2027 by Value

1.5.3 Global Anti-tumor Drug Price Trends Analysis from 2022 to 2027

1.6 COVID-19 Outbreak: Anti-tumor Drug Industry Impact

Chapter 2 Global Anti-tumor Drug Competition by Types, Applications, and Top Regions and Countries

2.1 Global Anti-tumor Drug (Volume and Value) by Type

2.1.1 Global Anti-tumor Drug Consumption and Market Share by Type (2016-2021)

2.1.2 Global Anti-tumor Drug Revenue and Market Share by Type (2016-2021)

2.2 Global Anti-tumor Drug (Volume and Value) by Application

2.2.1 Global Anti-tumor Drug Consumption and Market Share by Application (2016-2021)

2.2.2 Global Anti-tumor Drug Revenue and Market Share by Application (2016-2021)

2.3 Global Anti-tumor Drug (Volume and Value) by Regions

2.3.1 Global Anti-tumor Drug Consumption and Market Share by Regions (2016-2021)

2.3.2 Global Anti-tumor Drug Revenue and Market Share by Regions (2016-2021)

Chapter 3 Production Market Analysis

3.1 Global Production Market Analysis

3.1.1 2016-2021 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis

3.1.2 2016-2021 Major Manufacturers Performance and Market Share

3.2 Regional Production Market Analysis

3.2.1 2016-2021 Regional Market Performance and Market Share

3.2.2 North America Market

3.2.3 East Asia Market

3.2.4 Europe Market

3.2.5 South Asia Market

3.2.6 Southeast Asia Market

3.2.7 Middle East Market

3.2.8 Africa Market

3.2.9 Oceania Market

3.2.10 South America Market

3.2.11 Rest of the World Market

Chapter 4 Global Anti-tumor Drug Sales, Consumption, Export, Import by Regions (2016-2021)

4.1 Global Anti-tumor Drug Consumption by Regions (2016-2021)

4.2 North America Anti-tumor Drug Sales, Consumption, Export, Import (2016-2021)

4.3 East Asia Anti-tumor Drug Sales, Consumption, Export, Import (2016-2021)

4.4 Europe Anti-tumor Drug Sales, Consumption, Export, Import (2016-2021)

4.5 South Asia Anti-tumor Drug Sales, Consumption, Export, Import (2016-2021)

4.6 Southeast Asia Anti-tumor Drug Sales, Consumption, Export, Import (2016-2021)

4.7 Middle East Anti-tumor Drug Sales, Consumption, Export, Import (2016-2021)

4.8 Africa Anti-tumor Drug Sales, Consumption, Export, Import (2016-2021)

4.9 Oceania Anti-tumor Drug Sales, Consumption, Export, Import (2016-2021)

4.10 South America Anti-tumor Drug Sales, Consumption, Export, Import (2016-2021)

Chapter 5 North America Anti-tumor Drug Market Analysis

5.1 North America Anti-tumor Drug Consumption and Value Analysis

5.1.1 North America Anti-tumor Drug Market Under COVID-19

5.2 North America Anti-tumor Drug Consumption Volume by Types

5.3 North America Anti-tumor Drug Consumption Structure by Application

5.4 North America Anti-tumor Drug Consumption by Top Countries

5.4.1 United States Anti-tumor Drug Consumption Volume from 2016 to 2021

5.4.2 Canada Anti-tumor Drug Consumption Volume from 2016 to 2021

5.4.3 Mexico Anti-tumor Drug Consumption Volume from 2016 to 2021

Chapter 6 East Asia Anti-tumor Drug Market Analysis

6.1 East Asia Anti-tumor Drug Consumption and Value Analysis

6.1.1 East Asia Anti-tumor Drug Market Under COVID-19

6.2 East Asia Anti-tumor Drug Consumption Volume by Types

6.3 East Asia Anti-tumor Drug Consumption Structure by Application

6.4 East Asia Anti-tumor Drug Consumption by Top Countries

6.4.1 China Anti-tumor Drug Consumption Volume from 2016 to 2021

6.4.2 Japan Anti-tumor Drug Consumption Volume from 2016 to 2021

6.4.3 South Korea Anti-tumor Drug Consumption Volume from 2016 to 2021

Chapter 7 Europe Anti-tumor Drug Market Analysis

7.1 Europe Anti-tumor Drug Consumption and Value Analysis

7.1.1 Europe Anti-tumor Drug Market Under COVID-19

7.2 Europe Anti-tumor Drug Consumption Volume by Types

7.3 Europe Anti-tumor Drug Consumption Structure by Application

7.4 Europe Anti-tumor Drug Consumption by Top Countries

7.4.1 Germany Anti-tumor Drug Consumption Volume from 2016 to 2021

7.4.2 UK Anti-tumor Drug Consumption Volume from 2016 to 2021

7.4.3 France Anti-tumor Drug Consumption Volume from 2016 to 2021

7.4.4 Italy Anti-tumor Drug Consumption Volume from 2016 to 2021

7.4.5 Russia Anti-tumor Drug Consumption Volume from 2016 to 2021

7.4.6 Spain Anti-tumor Drug Consumption Volume from 2016 to 2021

7.4.7 Netherlands Anti-tumor Drug Consumption Volume from 2016 to 2021

7.4.8 Switzerland Anti-tumor Drug Consumption Volume from 2016 to 2021

7.4.9 Poland Anti-tumor Drug Consumption Volume from 2016 to 2021

Chapter 8 South Asia Anti-tumor Drug Market Analysis

8.1 South Asia Anti-tumor Drug Consumption and Value Analysis

8.1.1 South Asia Anti-tumor Drug Market Under COVID-19

8.2 South Asia Anti-tumor Drug Consumption Volume by Types

8.3 South Asia Anti-tumor Drug Consumption Structure by Application

8.4 South Asia Anti-tumor Drug Consumption by Top Countries

8.4.1 India Anti-tumor Drug Consumption Volume from 2016 to 2021

8.4.2 Pakistan Anti-tumor Drug Consumption Volume from 2016 to 2021

8.4.3 Bangladesh Anti-tumor Drug Consumption Volume from 2016 to 2021

Chapter 9 Southeast Asia Anti-tumor Drug Market Analysis

9.1 Southeast Asia Anti-tumor Drug Consumption and Value Analysis

9.1.1 Southeast Asia Anti-tumor Drug Market Under COVID-19

9.2 Southeast Asia Anti-tumor Drug Consumption Volume by Types

9.3 Southeast Asia Anti-tumor Drug Consumption Structure by Application

9.4 Southeast Asia Anti-tumor Drug Consumption by Top Countries

9.4.1 Indonesia Anti-tumor Drug Consumption Volume from 2016 to 2021

9.4.2 Thailand Anti-tumor Drug Consumption Volume from 2016 to 2021

9.4.3 Singapore Anti-tumor Drug Consumption Volume from 2016 to 2021

9.4.4 Malaysia Anti-tumor Drug Consumption Volume from 2016 to 2021

9.4.5 Philippines Anti-tumor Drug Consumption Volume from 2016 to 2021

9.4.6 Vietnam Anti-tumor Drug Consumption Volume from 2016 to 2021

9.4.7 Myanmar Anti-tumor Drug Consumption Volume from 2016 to 2021

Chapter 10 Middle East Anti-tumor Drug Market Analysis

10.1 Middle East Anti-tumor Drug Consumption and Value Analysis

10.1.1 Middle East Anti-tumor Drug Market Under COVID-19

10.2 Middle East Anti-tumor Drug Consumption Volume by Types

10.3 Middle East Anti-tumor Drug Consumption Structure by Application

10.4 Middle East Anti-tumor Drug Consumption by Top Countries

10.4.1 Turkey Anti-tumor Drug Consumption Volume from 2016 to 2021

10.4.2 Saudi Arabia Anti-tumor Drug Consumption Volume from 2016 to 2021

10.4.3 Iran Anti-tumor Drug Consumption Volume from 2016 to 2021

10.4.4 United Arab Emirates Anti-tumor Drug Consumption Volume from 2016 to 2021

10.4.5 Israel Anti-tumor Drug Consumption Volume from 2016 to 2021

10.4.6 Iraq Anti-tumor Drug Consumption Volume from 2016 to 2021

10.4.7 Qatar Anti-tumor Drug Consumption Volume from 2016 to 2021

10.4.8 Kuwait Anti-tumor Drug Consumption Volume from 2016 to 2021

10.4.9 Oman Anti-tumor Drug Consumption Volume from 2016 to 2021

Chapter 11 Africa Anti-tumor Drug Market Analysis

11.1 Africa Anti-tumor Drug Consumption and Value Analysis

11.1.1 Africa Anti-tumor Drug Market Under COVID-19

11.2 Africa Anti-tumor Drug Consumption Volume by Types

11.3 Africa Anti-tumor Drug Consumption Structure by Application

11.4 Africa Anti-tumor Drug Consumption by Top Countries

11.4.1 Nigeria Anti-tumor Drug Consumption Volume from 2016 to 2021

11.4.2 South Africa Anti-tumor Drug Consumption Volume from 2016 to 2021

11.4.3 Egypt Anti-tumor Drug Consumption Volume from 2016 to 2021

11.4.4 Algeria Anti-tumor Drug Consumption Volume from 2016 to 2021

11.4.5 Morocco Anti-tumor Drug Consumption Volume from 2016 to 2021

Chapter 12 Oceania Anti-tumor Drug Market Analysis

12.1 Oceania Anti-tumor Drug Consumption and Value Analysis

12.2 Oceania Anti-tumor Drug Consumption Volume by Types

12.3 Oceania Anti-tumor Drug Consumption Structure by Application

12.4 Oceania Anti-tumor Drug Consumption by Top Countries

12.4.1 Australia Anti-tumor Drug Consumption Volume from 2016 to 2021

12.4.2 New Zealand Anti-tumor Drug Consumption Volume from 2016 to 2021

Chapter 13 South America Anti-tumor Drug Market Analysis

13.1 South America Anti-tumor Drug Consumption and Value Analysis

13.1.1 South America Anti-tumor Drug Market Under COVID-19

13.2 South America Anti-tumor Drug Consumption Volume by Types

13.3 South America Anti-tumor Drug Consumption Structure by Application

13.4 South America Anti-tumor Drug Consumption Volume by Major Countries

13.4.1 Brazil Anti-tumor Drug Consumption Volume from 2016 to 2021

13.4.2 Argentina Anti-tumor Drug Consumption Volume from 2016 to 2021

13.4.3 Columbia Anti-tumor Drug Consumption Volume from 2016 to 2021

13.4.4 Chile Anti-tumor Drug Consumption Volume from 2016 to 2021

13.4.5 Venezuela Anti-tumor Drug Consumption Volume from 2016 to 2021

13.4.6 Peru Anti-tumor Drug Consumption Volume from 2016 to 2021

13.4.7 Puerto Rico Anti-tumor Drug Consumption Volume from 2016 to 2021

13.4.8 Ecuador Anti-tumor Drug Consumption Volume from 2016 to 2021

Chapter 14 Company Profiles and Key Figures in Anti-tumor Drug Business

14.1 Roche

14.1.1 Roche Company Profile

14.1.2 Roche Anti-tumor Drug Product Specification

14.1.3 Roche Anti-tumor Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.2 Takeda

14.2.1 Takeda Company Profile

14.2.2 Takeda Anti-tumor Drug Product Specification

14.2.3 Takeda Anti-tumor Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.3 Bristol-Myers Squibb

14.3.1 Bristol-Myers Squibb Company Profile

14.3.2 Bristol-Myers Squibb Anti-tumor Drug Product Specification

14.3.3 Bristol-Myers Squibb Anti-tumor Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.4 Novartis

14.4.1 Novartis Company Profile

14.4.2 Novartis Anti-tumor Drug Product Specification

14.4.3 Novartis Anti-tumor Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.5 Pfizer

14.5.1 Pfizer Company Profile

14.5.2 Pfizer Anti-tumor Drug Product Specification

14.5.3 Pfizer Anti-tumor Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.6 Celgene

14.6.1 Celgene Company Profile

14.6.2 Celgene Anti-tumor Drug Product Specification

14.6.3 Celgene Anti-tumor Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.7 AstraZeneca

14.7.1 AstraZeneca Company Profile

14.7.2 AstraZeneca Anti-tumor Drug Product Specification

14.7.3 AstraZeneca Anti-tumor Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.8 Johnson & Johnson

14.8.1 Johnson & Johnson Company Profile

14.8.2 Johnson & Johnson Anti-tumor Drug Product Specification

14.8.3 Johnson & Johnson Anti-tumor Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.9 Amgen

14.9.1 Amgen Company Profile

14.9.2 Amgen Anti-tumor Drug Product Specification

14.9.3 Amgen Anti-tumor Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.10 Eli Lilly

14.10.1 Eli Lilly Company Profile

14.10.2 Eli Lilly Anti-tumor Drug Product Specification

14.10.3 Eli Lilly Anti-tumor Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.11 Biogen Idec

14.11.1 Biogen Idec Company Profile

14.11.2 Biogen Idec Anti-tumor Drug Product Specification

14.11.3 Biogen Idec Anti-tumor Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.12 Otsuka

14.12.1 Otsuka Company Profile

14.12.2 Otsuka Anti-tumor Drug Product Specification

14.12.3 Otsuka Anti-tumor Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.13 Astellas

14.13.1 Astellas Company Profile

14.13.2 Astellas Anti-tumor Drug Product Specification

14.13.3 Astellas Anti-tumor Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.14 Eisai

14.14.1 Eisai Company Profile

14.14.2 Eisai Anti-tumor Drug Product Specification

14.14.3 Eisai Anti-tumor Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.15 Bayer

14.15.1 Bayer Company Profile

14.15.2 Bayer Anti-tumor Drug Product Specification

14.15.3 Bayer Anti-tumor Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.16 Merck & Co

14.16.1 Merck & Co Company Profile

14.16.2 Merck & Co Anti-tumor Drug Product Specification

14.16.3 Merck & Co Anti-tumor Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.17 Teva

14.17.1 Teva Company Profile

14.17.2 Teva Anti-tumor Drug Product Specification

14.17.3 Teva Anti-tumor Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.18 Sanofi

14.18.1 Sanofi Company Profile

14.18.2 Sanofi Anti-tumor Drug Product Specification

14.18.3 Sanofi Anti-tumor Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Chapter 15 Global Anti-tumor Drug Market Forecast (2022-2027)

15.1 Global Anti-tumor Drug Consumption Volume, Revenue and Price Forecast (2022-2027)

15.1.1 Global Anti-tumor Drug Consumption Volume and Growth Rate Forecast (2022-2027)

15.1.2 Global Anti-tumor Drug Value and Growth Rate Forecast (2022-2027)

15.2 Global Anti-tumor Drug Consumption Volume, Value and Growth Rate Forecast by Region (2022-2027)

15.2.1 Global Anti-tumor Drug Consumption Volume and Growth Rate Forecast by Regions (2022-2027)

15.2.2 Global Anti-tumor Drug Value and Growth Rate Forecast by Regions (2022-2027)

15.2.3 North America Anti-tumor Drug Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.4 East Asia Anti-tumor Drug Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.5 Europe Anti-tumor Drug Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.6 South Asia Anti-tumor Drug Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.7 Southeast Asia Anti-tumor Drug Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.8 Middle East Anti-tumor Drug Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.9 Africa Anti-tumor Drug Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.10 Oceania Anti-tumor Drug Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.11 South America Anti-tumor Drug Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.3 Global Anti-tumor Drug Consumption Volume, Revenue and Price Forecast by Type (2022-2027)

15.3.1 Global Anti-tumor Drug Consumption Forecast by Type (2022-2027)

15.3.2 Global Anti-tumor Drug Revenue Forecast by Type (2022-2027)

15.3.3 Global Anti-tumor Drug Price Forecast by Type (2022-2027)

15.4 Global Anti-tumor Drug Consumption Volume Forecast by Application (2022-2027)

15.5 Anti-tumor Drug Market Forecast Under COVID-19

Chapter 16 Conclusions

Research Methodology